drugset / Trial / NCT06027437

A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants

NCT06027437

Phase 1 Completed 21 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.

Timeline

Start
2023-09-05
Primary completion
2023-11-10
Completion
2023-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Danicamtiv Small molecule

Indications

No indication recorded.